Xylose Absorption Test

Introduction

  • Xylose Absorption Test is a laboratory test used to assess the absorptive function of the small intestine.
  • The test uses D-xylose, a simple sugar that can be absorbed without significant digestion.
  • After oral administration, D-xylose is absorbed mainly through the small intestinal mucosa.
  • The amount of D-xylose in blood and/or urine is measured after administration.
  • A normal result generally indicates that the small intestinal mucosa is absorbing adequately.
  • A low D-xylose level may suggest impaired intestinal absorption.
  • The test can be useful in the evaluation of malabsorption syndromes.
  • It may help assess intestinal disorders such as celiac disease and other mucosal diseases.
  • Renal function and incomplete urine collection can affect the test results, particularly when urinary excretion is measured.

Principle

  • The Xylose Absorption Test is based on the ability of the small intestine to absorb D-xylose.
  • D-xylose is a simple sugar that does not require significant enzymatic digestion before absorption.
  • A measured amount of D-xylose is given orally to the fasting patient.
  • D-xylose is absorbed mainly through the small intestinal mucosa and enters the bloodstream.
  • After absorption, a portion of D-xylose is excreted through the kidneys in urine.
  • The amount of D-xylose in blood and/or urine is measured after administration.
  • Normal D-xylose absorption suggests relatively normal small intestinal mucosal function.
  • Reduced D-xylose absorption may indicate impaired absorption due to small intestinal mucosal disease.
  • Urinary results are also influenced by renal function and completeness of urine collection.

Patient Preparation

  • The patient is generally required to fast overnight before the test.
  • Water may be allowed according to the laboratory protocol.
  • Certain medications and medical conditions may affect the results.
  • Proper patient preparation should follow the laboratory’s validated procedure.

Requirements

  1. Sample:
    • Blood samples: To measure the plasma xylose concentration.
    • Urine samples: To measure the xylose excretion over a certain period (usually 5 hours).
  2. Reagents:
    • D-xylose solution (typically 25 grams of D-xylose dissolved in water).
    • Glucose solution for baseline measurements (optional in some tests).
    • Urine collection containers (for collection of timed urine samples).
    • Reagents for plasma glucose determination (if needed for related tests).
  3. Apparatus:
    • Syringes or oral dosing cups for administering the D-xylose.
    • Blood collection tubes for plasma or serum analysis.
    • Centrifuge (if required for sample preparation).
    • Spectrophotometer or auto-analyzer for xylose or glucose measurement in blood/urine.

Procedure

  1. Preparation of the Patient
    • The patient must usually fast for 8-12 hours before the test to ensure baseline readings are accurate and unaffected by food.
    • In some cases, patients may be asked to refrain from medications, especially those that could interfere with intestinal absorption (e.g., antibiotics).
  1. Administering D-Xylose
    • A measured dose of D-xylose (typically 25 grams) is given orally to the patient dissolved in water.
    • The patient should be instructed to swallow the solution without eating or drinking anything else for 2–5 hours.
  1. Collection of Blood Samples
    • Blood samples are collected at specific intervals (typically at 1 hour, 2 hours, and 5 hours) after ingesting xylose. These samples are analyzed for plasma xylose concentration.
    • If plasma xylose is low at any given interval, it indicates reduced absorption.
  1. Collection of Urine Samples
    • Urine is collected over 5 hours following the ingestion of xylose. The amount of xylose in the urine is measured to assess renal excretion and intestinal absorption.
    • Reduced excretion of xylose in the urine indicates malabsorption.
  1. Analysis of Samples
    • Plasma xylose levels are measured using colorimetric assays, high-performance liquid chromatography (HPLC), or other automated techniques.
    • The amount of xylose in the urine is determined by titration or chromatographic methods.

Interpretation of Results

  1. Normal Results:
    • In a healthy individual, the plasma xylose concentration will increase following ingestion, and the urinary excretion of xylose will be proportional to the amount ingested.
    • Typically, more than 25 grams of xylose is absorbed, and a significant portion will be excreted in the urine within 5 hours.
    • Plasma xylose peaks at approximately 60-90 minutes after ingestion.
  2. Abnormal Results (Malabsorption):
    • Reduced plasma xylose levels at 1 hour and 2 hours suggest impaired absorption from the small intestine.
    • Low xylose excretion in urine (less than 5 grams) indicates malabsorption of xylose, suggesting conditions like:
      • Celiac disease
      • Tropical sprue
      • Small bowel disease
      • Intestinal bacterial overgrowth (SIBO)
      • Short bowel syndrome
    • In cases of severe malabsorption, minimal or no xylose may be detected in the urine.
  3. Factors Affecting Results:
    • Renal dysfunction may impair the ability of the kidneys to excrete xylose, leading to false positives for malabsorption.
    • Acute illnesses or inflammatory conditions affecting the intestine may also influence results.

Clinical Significance

The Xylose Absorption Test is primarily used to diagnose malabsorption syndromes, which can occur due to various causes, including:

  1. Celiac Disease:
    • Individuals with gluten intolerance have impaired intestinal absorption of nutrients, including xylose.
  2. Tropical Sprue:
    • This condition involves intestinal malabsorption due to infections or dietary factors, reducing xylose absorption.
  3. Small Bowel Disease:
    • Disorders affecting the small intestine (e.g., Crohn’s disease, irradiation enteritis) can reduce the absorptive capacity for xylose and other nutrients.
  4. Short Bowel Syndrome:
    • Patients undergoing intestinal resection or short bowel syndrome may demonstrate impaired xylose absorption.
  5. Intestinal Bacterial Overgrowth (SIBO):
    • Excessive bacteria in the small intestine may interfere with nutrient absorption, including xylose, leading to malabsorption.
  6. Assessing Nutritional Absorption:
    • The test can be used as an initial screening tool to determine if an individual’s nutritional deficiencies might be due to malabsorption from the small intestine.

Limitations

  1. Non-Specific:
    • Although the test is useful in identifying general malabsorption, it cannot identify the specific cause of the malabsorption. Further testing (e.g., endoscopy, biopsy, or genetic testing) may be needed to confirm the underlying cause.
  2. False Results Due to Renal Dysfunction:
    • Kidney diseases can affect the excretion of xylose, potentially leading to false-positive results for malabsorption.
  3. Influence of Diet and Medication:
    • Diet or recent consumption of medications like antibiotics may affect intestinal flora or absorption, impacting test results.
  4. Not Suitable for All Populations:
    • This test may not be suitable for patients with severe renal failure or diabetes, as these conditions may interfere with test results.